Dietary phosphate (Pi) (Pi)

Dietary phosphate refers to the inorganic phosphorus compounds ingested through food that are absorbed in the gastrointestinal tract, primarily in the duodenum and jejunum [1, 2]. In healthy individuals, the kidneys maintain phosphate homeostasis by excreting excess amounts; however, in patients with chronic kidney disease (CKD), this excretory capacity is severely diminished, leading to hyperphosphatemia [2, 4]. Elevated serum phosphate levels are a primary driver of secondary hyperparathyroidism, renal osteodystrophy, and systemic vascular calcification, which significantly increases cardiovascular mortality [2, 4]. To manage these risks, dietary phosphate is targeted within the gut lumen using non-absorbable binding agents such as sevelamer carbonate [1, 3]. These agents contain functional groups, like protonated amines, that ionically bind phosphate ions to form insoluble complexes, preventing their absorption and facilitating their excretion in the feces [1, 3]. By sequestering phosphate before it enters the bloodstream, these therapies help maintain mineral balance and mitigate the progression of CKD-related complications [1, 2]. This approach is essential for patients on dialysis who cannot otherwise regulate phosphorus levels through diet alone [1, 4].

Other names

Inorganic phosphateOrthophosphatePhosphorusIntestinal phosphatePO4

Sevelamer carbonate acts as a non-absorbed phosphate binder; it contains multiple amines that become protonated in the gastrointestinal tract, allowing them to bind dietary phosphate through ionic and hydrogen bonding, thereby preventing its absorption into the bloodstream [1, 3].